Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone

Purpose To examine the association of individual and combined indicators of diabetes control with diabetic retinopathy and diabetic macular edema. Materials and methods In this clinical, cross-sectional study, 613 adults with type 2 diabetes (372 any diabetic retinopathy; 183 any diabetic macular edema) were examined. Diabetic retinopathy was assessed from fundus photographs; diabetic macular edema from Ocular Coherence Tomography scans; and HbA1c and serum lipid values from fasting blood samples. Poor glucose control was defined as HbA1c≥7%; poor blood pressure control as SBP≥130/DBP≥80; and poor lipid control as total cholesterol:HDL ratio≥4.0. The association of poor glucose control, poor blood pressure control and poor lipid control alone and in combination (poor glucose & blood pressure control; poor glucose & lipid control; poor blood pressure & lipid control; and poor glucose, blood pressure & lipid control) with diabetic retinopathy/diabetic macular edema was examined using multiple logistic regression models. Results Patients’ mean±standard deviation age was 64.9±11.6 years (57% male). In adjusted models, compared to those with good control of all indicators (n = 99, 18.3%), the odds ratio (95% Confidence Interval) of having any diabetic retinopathy was 2.44 (1.34–4.46), 3.75 (1.75–8.07), 4.64 (2.13–10.12) and 2.28 (1.01–5.16) for poor glucose control only; poor glucose & blood pressure control; poor glucose & lipid control; and poor glucose, blood pressure & lipid control, respectively. Correspondingly for diabetic macular edema, they were 3.19 (1.55–6.59); 3.60 (1.58–8.22); 2.76 (1.18–6.44); and 3.01 (1.18–7.67), respectively. Odds were not significantly increased for other indicators. Discussion Compared to individual indicators of poor diabetes control, risk of diabetic retinopathy and diabetic macular edema increased three to fourfold with a combination of these indicators. Targeting combined diabetes control indicators is important to reduce risk of diabetic retinopathy/diabetic macular edema.

[1]  T. Wong,et al.  Rationale and Methodology for a Population-Based Study of Eye Diseases in Malay People: The Singapore Malay Eye Study (SiMES) , 2007, Ophthalmic epidemiology.

[2]  T. Wong,et al.  Glycemic and blood pressure control in an asian malay population with diabetes and diabetic retinopathy. , 2010, Archives of ophthalmology.

[3]  R. Klein,et al.  The Epidemiology of Eye Diseases in Diabetes , 2008 .

[4]  C. Sabanayagam,et al.  HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics , 2017, Journal of diabetes.

[5]  B. Hoogwerf,et al.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. , 1996, Archives of ophthalmology.

[6]  G. Dagenais,et al.  Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. , 2001, Archives of internal medicine.

[7]  Malla Ok,et al.  Vision 2020: the right to sight. , 2004 .

[8]  R. Raman,et al.  Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic , Blood Pressure and Lipid Control , 2012 .

[9]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[10]  Matthew D. Davis,et al.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.

[11]  K. Pesudovs,et al.  The impact of diabetic retinopathy: understanding the patient's perspective , 2010, British Journal of Ophthalmology.

[12]  R. Raman,et al.  Prevalence and Risk Factors of Diabetic Retinopathy in Subjects with Suboptimal Glycemic, Blood Pressure and Lipid Control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33) , 2012, Current eye research.

[13]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[14]  S. Arcona,et al.  Assessing the importance of predictors in unplanned hospital readmissions for chronic obstructive pulmonary disease , 2015, ClinicoEconomics and outcomes research : CEOR.

[15]  R. Bullock,et al.  Validation of a 6 item cognitive impairment test with a view to primary care usage , 1999, International journal of geriatric psychiatry.

[16]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[17]  T. Wong,et al.  Management of diabetic retinopathy: a systematic review. , 2007, JAMA.

[18]  Rury R Holman,et al.  Long-term follow-up after tight control of blood pressure in type 2 diabetes. , 2008, The New England journal of medicine.

[19]  J. Shaw,et al.  Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. , 2005, Diabetes care.

[20]  Vishali Gupta,et al.  Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. , 2004, American journal of ophthalmology.

[21]  M. Woodward,et al.  Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes , 2009, Diabetes Care.

[22]  R. Raman,et al.  Influence of serum lipids on clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. , 2010, Ophthalmology.

[23]  R. Hogg,et al.  Dyslipidemia and Diabetic Macular Edema: A Systematic Review and Meta-Analysis. , 2014, Ophthalmology.

[24]  G. Chodick,et al.  The association between glycemic, lipids and blood pressure control among Israeli diabetic patients. , 2007, QJM : monthly journal of the Association of Physicians.

[25]  S. Hori Guidelines for the Management of Diabetic Retinopathy for the Internist , 2002 .

[26]  W. Howard Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .

[27]  S. Grundy,et al.  Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2006, Diabetes Care.

[28]  D. Budescu Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression. , 1993 .

[29]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[30]  T. Wong,et al.  Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy , 2012, Clinical & experimental ophthalmology.

[31]  Walter T Ambrosius,et al.  The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. , 2014, Ophthalmology.

[32]  Uk-Prospective-Diabetes-Study-Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[33]  Sarah J. Beaton,et al.  Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. , 2004, Diabetes care.

[34]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.